These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy. Muthu MS; Mehata AK; Viswanadh MK Nanomedicine (Lond); 2017 Mar; 12(6):577-580. PubMed ID: 28244815 [No Abstract] [Full Text] [Related]
4. Facile Supramolecular Approach to Nucleic-Acid-Driven Activatable Nanotheranostics That Overcome Drawbacks of Photodynamic Therapy. Li X; Yu S; Lee D; Kim G; Lee B; Cho Y; Zheng BY; Ke MR; Huang JD; Nam KT; Chen X; Yoon J ACS Nano; 2018 Jan; 12(1):681-688. PubMed ID: 29232105 [TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted nanomedicines for cancer theranostics. Arranja AG; Pathak V; Lammers T; Shi Y Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762 [TBL] [Abstract][Full Text] [Related]
6. Artificial Molecular Machines in Nanotheranostics. Yu G; Yung BC; Zhou Z; Mao Z; Chen X ACS Nano; 2018 Jan; 12(1):7-12. PubMed ID: 29283247 [TBL] [Abstract][Full Text] [Related]
7. "Trojan Horse" DNA Nanostructure for Personalized Theranostics: Can It Knock on the Door of Preclinical Practice? Li Y; Yang S; Zheng J; Zou Z; Yang R; Tan W Langmuir; 2018 Dec; 34(49):15028-15044. PubMed ID: 30295491 [TBL] [Abstract][Full Text] [Related]
8. Development of Graphene-Based Materials with the Targeted Action for Cancer Theranostics. Semenov KN; Shemchuk OS; Ageev SV; Andoskin PA; Iurev GO; Murin IV; Kozhukhov PK; Maystrenko DN; Molchanov OE; Kholmurodova DK; Rizaev JA; Sharoyko VV Biochemistry (Mosc); 2024 Aug; 89(8):1362-1391. PubMed ID: 39245451 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer. Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139 [TBL] [Abstract][Full Text] [Related]
10. Activatable Theranostics. Huang P Curr Med Chem; 2019; 26(8):1310. PubMed ID: 31189459 [No Abstract] [Full Text] [Related]
11. Nanomaterials for theranostics: recent advances and future challenges. Lim EK; Kim T; Paik S; Haam S; Huh YM; Lee K Chem Rev; 2015 Jan; 115(1):327-94. PubMed ID: 25423180 [No Abstract] [Full Text] [Related]
12. Nanohybrids - cancer theranostics for tiny tumor clusters. Dhandapani R; Sethuraman S; Subramanian A J Control Release; 2019 Apr; 299():21-30. PubMed ID: 30797000 [TBL] [Abstract][Full Text] [Related]
13. Theranostic application of nanoemulsions in chemotherapy. Gorain B; Choudhury H; Nair AB; Dubey SK; Kesharwani P Drug Discov Today; 2020 Jul; 25(7):1174-1188. PubMed ID: 32344042 [TBL] [Abstract][Full Text] [Related]
15. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis. Kundu P; Singh D; Singh A; Sahoo SK Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694 [TBL] [Abstract][Full Text] [Related]
16. A biomimetic theranostic O Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939 [TBL] [Abstract][Full Text] [Related]
17. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine. Mohammadi M; Ramezani M; Abnous K; Alibolandi M Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259 [TBL] [Abstract][Full Text] [Related]
18. Two-Dimensional Nanomaterials for Cancer Nanotheranostics. Chen Y; Wu Y; Sun B; Liu S; Liu H Small; 2017 Mar; 13(10):. PubMed ID: 28075057 [TBL] [Abstract][Full Text] [Related]
19. Fe Li Y; Zhang H Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317 [TBL] [Abstract][Full Text] [Related]
20. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging. Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951 [No Abstract] [Full Text] [Related] [Next] [New Search]